Ikerian

Ikerian, the parent company of RetinAI, provides a vendor-neutral data management and AI analysis platform called Discovery for ophthalmology and other therapeutic areas. The software enables pharmaceutical companies, clinics, and researchers to aggregate medical imaging and clinical data, perform automated biomarker analysis using CE-marked machine learning models, and manage clinical trial workflows. The platform supports disease monitoring for conditions such as AMD, diabetic retinopathy, and glaucoma by harmonizing data from various imaging devices.